Neurol. praxi. 2010;11(6):406-409

Late Lyme neuroborreliosis or post-Lyme borreliosis syndrome? A case report

MUDr.Ladislav Gurčík, PhD.
Neurologické oddelenie VNsP Levoča a. s.

The paper presents a case report of a patient with a history of healed Lyme borreliosis who, years later, developed symptoms of late (chronic)

Lyme neuroborreliosis (LNB) which was confirmed and treated appropriately. According to the most recent EFNS guidelines on the diagnosis

and management of European Lyme neuroborreliosis, late LNB is manifested by chronic mononeuropathy, radiculopathy or polyneuropathy

in the peripheral nervous system and by cerebral vasculitis, chronic progressive encephalitis or encephalomyelitis with tetraspastic syndrome,

spastic-ataxic gait disorder and disturbed micturition in the CNS. The diagnosis of late LNB is based on the history of tick attachment,

the presence of erythema migrans (EM), the clinical presentation and cerebrospinal fluid (CSF) analysis; exceptionally, however, it may be

established even in patients with no history of tick exposure or those who have not experienced EM. When the symptoms persist for more

than six months following standard treatment and the CSF finding fails to show evidence of Borrelia infection, the condition is referred to

as post-Lyme disease syndrome (PLDS). The paper also briefly mentions the differences between late LNB and PLDS.

Keywords: chronic mononeuropathy, radiculopathy, polyneuropathy, chronic encephalomyelitis, post-Lyme disease syndrome

Published: December 31, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gurčík L. Late Lyme neuroborreliosis or post-Lyme borreliosis syndrome? A case report. Neurol. praxi. 2010;11(6):406-409.
Download citation

References

  1. Bartůnek P, Bojar M, Calda P, Diblík P, Hercogová J, Hoza J, Hulínská D, Janovská D, Pícha D, Valešová M. Lymeská borelióza. Praha: Grada - Avicenum 2006: 123.
  2. Batinac T, Petranovic D, Zamolo G, Zamolo G, Petranovic D, Ruzic A. Lyme borreliosis and multiple sclerosis are associated with primary effusion lymphoma. Med Hypotheses. 2007; 69: 117-119. Go to original source... Go to PubMed...
  3. Bednářová J. Cerebrospinal-Fluid Profile in Neuroborreliosis and Its Diagnostic Significance. Folia Microbiol. 2006; 51(6): 599-603. Go to original source... Go to PubMed...
  4. Bednářová J, Štourač P. Intratekální syntéza specifických antivirových protilátek u atakovitého a primárně chronickoprogresivního průběhu roztroušené sklerózy. Neurol. pro praxi 2009; 10(5): 279-281.
  5. Bednářová J, Štourač P, Adam P. Relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol Scand. 2005; 112(2): 97-102. Go to original source... Go to PubMed...
  6. Blanc F, Jaulhac B, Fleury M, de Seze J, de Martino SJ, Remy V. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 2007; 69: 953-958. Go to original source... Go to PubMed...
  7. Bojar M. Neuroborrelióza - současné názory na patogenezi, diagnostiku a léčbu. Interní medicína pro praxi. 2002; 4: 154-160.
  8. Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005; 34: 1340-1345. Go to original source... Go to PubMed...
  9. Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008; 70(13): 992-1003. Go to original source... Go to PubMed...
  10. Fallon BA, Lipkin RB, Corbera KM, Yu S, Nobler MS, Keilp JG, Petkova E, Lisanby SH, Moeller JR, Slavov I, van Heertum R, Mensh BD, Sackeim HA. Regional Cerebral Blood Flow and Metabolic Rate in Persistent Lyme Encephalopathy. Arch Gen Psychiatry. 2009; 66(5): 554-563. Go to original source... Go to PubMed...
  11. Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC. A critical appraisal of, ,chronic Lyme disease." N Engl J Med. 2007; 357: 1422-1430. Go to original source... Go to PubMed...
  12. Fritzsche M. Chronic Lyme borreliosis at the root of multiple sclerosis - is a cure with antibiotics attainable? Med Hypotheses. 2005; 64: 438-448. Go to original source... Go to PubMed...
  13. Gurčík L. Súčasné trendy v diagnostike a liečbe neuroboreliózy. Neurol. pro praxi 2009; 10(3): 184-190.
  14. Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology. 1996; 46: 619-627. Go to original source...
  15. Hurley RA, Taber KH. Acute and chronic Lyme disease: controversies for neuropsychiatry. J Neuropsychiatry Clin Neurosci. 2008; 20: iv-6. Go to original source... Go to PubMed...
  16. Kalina P, Decker A, Kornel E, Halperin JJ. Lyme disease of the brainstem. Neuroradiology. 2005; 47: 903-907. Go to original source... Go to PubMed...
  17. Kaplan RF, Trevino RP, Johnson GM, Levy L, Dornbush R, Hu LT, Evans J, Weinstein A. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 2003; 60(12): 1916-1922. Go to original source... Go to PubMed...
  18. Ljostad U, Mygland A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol. 2008; 255(5): 732-737. Go to original source... Go to PubMed...
  19. Marques A, Brown MR, Fleisher TA. Natural Killer Cell Counts Are Not Different between Patients with Post-Lyme Disease Syndrome and Controls. CVI. 2009; 16: 1249-1250. Go to original source... Go to PubMed...
  20. Mygland A, Ljastad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. European Journal of Neurology 2010; 17: 8-16. Go to original source... Go to PubMed...
  21. Rádulescu A, Tátulescu D, Perju-Dumbravá L, Flonta M, Astilean A, Horvat M. Controversies in late neuroborreliosis and multiple sclerosis - case series. Therapeutics, Pharmacology and Clinical Toxicology. 2009; 1: 57-62.
  22. Steere AC. Lyme disease. N Engl J Med. 2001; 345: 115-124. Go to original source... Go to PubMed...
  23. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43(9): 1089-1134. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.